Jennifer Ma
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
Papers in
- Oncology 16
- PARP inhibition in cancer therapy 5
- CAR-T cell therapy research 4
-
- DNA Repair Mechanisms 3
- Co-authors
- Nancy Y. Lee (7 shared papers)Nadeem Riaz (9 shared papers)Jeremy Setton (5 shared papers)Simon N. Powell (4 shared papers)Benjamin H. Lok (14 shared papers)Ghassan K. Abou‐Alfa (9 shared papers)Eileen M. O’Reilly (6 shared papers)Marinela Capanu (6 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (11 papers)Journal of Clinical Oncology (7 papers)Blood (3 papers)Cancer Medicine (2 papers)Cancer (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Jennifer Ma
45 papers receiving 830 citations
Peers
Comparison fields: 5 of 72
- Hepatology 114
- Oncology 266
- Cancer Research 146
- Pathology and Forensic Medicine 117
- Otorhinolaryngology 27
Countries citing papers authored by Jennifer Ma
This map shows the geographic impact of Jennifer Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Ma more than expected).
Fields of papers citing papers by Jennifer Ma
This network shows the impact of papers produced by Jennifer Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Ma. The network helps show where Jennifer Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Jennifer Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 149 | |
| 2 | 2013 | 89 | |
| 3 | 2013 | 83 | |
| 4 | Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. | 2013 | 80 |
| 5 | 2018 | 58 | |
| 6 | 2019 | 49 | |
| 7 | 2018 | 34 | |
| 8 | 2017 | 31 | |
| 9 | 2017 | 30 | |
| 10 | 2016 | 29 | |
| 11 | 2017 | 20 | |
| 12 | 2016 | 20 | |
| 13 | 2016 | 20 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2017 | 13 | |
| 17 | 2023 | 12 | |
| 18 | A Nonrandomized, Phase II Study of Sequential Irinotecan and Flavopiridol in Patients With Advanced Hepatocellular Carcinoma. | 2012 | 11 |
| 19 | 2022 | 10 | |
| 20 | 2018 | 9 |
About Jennifer Ma
Jennifer Ma is a scholar working on Oncology, Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine and Surgery, having authored 57 papers that have together received 838 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Mycobacterium research and diagnosis (4 papers), Head and Neck Cancer Studies (4 papers), Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Hepatology (114 citations), Oncology (266 citations), Cancer Research (146 citations), Pathology and Forensic Medicine (117 citations) and Otorhinolaryngology (27 citations). Jennifer Ma has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Nancy Y. Lee, Nadeem Riaz, Jeremy Setton, Simon N. Powell, Benjamin H. Lok, Ghassan K. Abou‐Alfa, Eileen M. O’Reilly, Marinela Capanu, Joanne F. Chou and J. Laird. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Blood, Cancer Medicine and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.